By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market on Tuesday that its second-quarter revenues declined around 2 percent year over year, as a 60 percent increase in product sales largely made up for its loss of grant and contract revenue.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $509,000 for the three-month period ended June 30, down from $517,000 for Q2 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.